(Q47808300)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Viktor Hlaváč

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Martin Oliverius

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

Beatrice Mohelnikova-Duchonova

7 March 2020

1

object named as

Beatrice Mohelnikova-Duchonova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Veronika Brynychova

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Matej Kocik

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Jan Hlavsa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Eva Honsova

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Jan Mazanec

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Zdenek Kala

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Bohuslav Melichar

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

11 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

669-682

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23934321%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00280-013-2246-2

7 March 2020

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Systemic treatment of advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

The role of ABC transporters in progression and clinical outcome of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Differences in transcript levels of ABC transporters between pancreatic adenocarcinoma and nonneoplastic tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

The equilibrative nucleoside transporter family, SLC29

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

The concentrative nucleoside transporter family, SLC28

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Polymorphic transporters and platinum pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Methotrexate-loxoprofen interaction: involvement of human organic anion transporters hOAT1 and hOAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Characterization of methotrexate transport and its drug interactions with human organic anion transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7]).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Expression of cytochrome P450 genes in CD34+ hematopoietic stem and progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Evaluation of reference genes and normalization strategy for quantitative real-time PCR in human pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Cell death induced by novel fluorinated taxanes in drug-sensitive and drug-resistant cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

CNT1 expression influences proliferation and chemosensitivity in drug-resistant pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Organic cation transporters are determinants of oxaliplatin cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2

Biobanking of human pancreas cancer tissue: impact of ex-vivo procurement times on RNA quality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-013-2246-2